Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: Four-year results of the look AHEAD trial

Archives of Internal Medicine

Volumn 170, Issue 17, 2010, Pages 1566-1575

  Wing, Rena R ^a   Bahnson, Judy L ^b   Bray, George A ^c,d   Clark, Jeanne M ^e   Coday, Mace ^f   Egan, Caitlin ^a   Espeland, Mark A ^b   Foreyt, John P ^g   Gregg, Edward W ^h   Goldman, Valerie ⁱ   Haffner, Steven M ^j   Hazuda, Helen ^w   Hill, James O ^k   Horton, Edward S ^l   Hubbard, Van S ^m   Jakicic, John ^d   Jeffery, Robert W ⁿ   Johnson, Karen C ^f   Kahn, Steven ^o   Killean, Tina ^p,q   Kitabchi, Abbas E ^r   Lewis, Cora E ^s   Manus, Cathy ^p,q   Maschak Carey, Barbara J ^t   Michaels, Sara ^p,q   Montez, Maria ^j   Montgomery, Brenda ^o   Nathan, David M ⁱ   Patricio, Jennifer ^u   Peters, Anne ^v   Pi Sunyer, Xavier ^u   Pownall, Henry ^g   Reboussin, David ^b   Rejeski, W Jack ^b   Rubin, Richard ^e   Safford, Monika ^s   Skarphol, Tricia ⁿ   Van Dorsten, Brent ^k   Wadden, Thomas A ^t   Wagenknecht, Lynne ^b   Wesche Thobaben, Jacqueline ^d   West, Delia S ^b   Williamson, Donald ^c   Yanovski, Susan Z ^m   more..

^a BROWN UNIVERSITY   (United States)

^b WAKE FOREST UNIVERSITY   (United States)

^c PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e DEPARTMENT OF PATHOLOGY   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

^h CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

ⁱ MASSACHUSETTS GENERAL HOSPITAL   (United States)

^j UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^k UNIVERSITY OF COLORADO   (United States)

^l JOSLIN DIABETES CENTER   (United States)

^m NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

ⁿ UNIVERSITY OF MINNESOTA   (United States)

^o VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^p Southwestern American Indian Center   (United States)

^q Southwestern American Indian Center   (United States)

^r University of Tennessee Downtown   (United States)

^s UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^t UNIVERSITY OF PENNSYLVANIA   (United States)

^u ST LUKE S ROOSEVELT HOSPITAL CENTER   (United States)

^v UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^w NONE

more..

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES CONTROL; DIABETES EDUCATION; DIASTOLIC BLOOD PRESSURE; FEMALE; FITNESS; FOLLOW UP; GLYCEMIC CONTROL; HUMAN; INCIDENCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; POSTMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL; WEIGHT CHANGE; WEIGHT REDUCTION; BLOOD; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR DISEASES; COMPLICATION; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; LIFESTYLE; METABOLISM; MIDDLE AGED; OVERWEIGHT; PATIENT EDUCATION; RISK FACTOR; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME; UNITED STATES;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; OBESITY; OVERWEIGHT; PATIENT EDUCATION AS TOPIC; PHYSICAL FITNESS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES; UNITED STATES; WEIGHT LOSS;

EID: 77957690115     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2010.334     Document Type: Article

References (50)

1. Look AHEAD Research Group; Pi-Sunyer X, Blackburn G, Brancati FL, et al. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care. 2007;30(6):1374-1383. (Pubitemid 46871141)
2. National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report [published correction appears in Obes Res. 1998;6(6):464]. Obes Res. 1998;6(suppl 2):51S-209S.
3. Wing RR, Koeske R, Epstein LH, Nowalk MP, Gooding W, Becker D. Long-term effects of modest weight loss in type II diabetic patients. Arch Intern Med. 1987;147(10):1749-1753. (Pubitemid 17159673)
4. Pi-Sunyer FX. Short-term medical benefits and adverse effects of weight loss. Ann Intern Med. 1993;119(7, pt 2):722-726.
5. Diabetes Prevention Program (DPP) Research Group. The Diabetes Prevention Program (DPP): description of lifestyle intervention. Diabetes Care. 2002;25(12):2165-2171.
6. Wing RR. Behavioral approaches to the treatment of obesity. In: Bray G, Bouchard C, eds. Handbook of Obesity: Clinical Applications. 2nd ed. New York, NY: Marcel Dekker Inc; 2004.
7. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: the Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20(4):537-544.
8. Tuomilehto J, Lindström J, Eriksson JG, et al; Finnish Diabetes Prevention Study Group. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344(18):1343-1350.
9. Ryan DH, Espeland MA, Foster GD, et al; Look AHEAD Research Group. Look AHEAD (Action for Health in Diabetes): design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials. 2003;24(5):610-628.
10. Look AHEAD Research Group; Wadden TA, West DS, Delahanty L, et al. The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it [published correction appears in Obesity (Silver Spring). 2007;15(5):1339]. Obesity (Silver Spring). 2006;14(5):737-752.
11. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 1972;18(6):499-502.
12. Jakicic JM, Jaramillo SA, Balasubramanyam A, et al; Look AHEAD Study Group. Effect of a lifestyle intervention on change in cardiorespiratory fitness in adults with type 2 diabetes: results from the Look AHEAD study. Int J Obes (Lond). 2009;33(3):305-316.
13. Look Ahead Research Group; Bray G, Gregg E, Haffner S, et al. Baseline characteristics of the randomised cohort from the Look AHEAD (Action for Health in Diabetes) study. Diab Vasc Dis Res. 2006;3(3):202-215.
14. Whelton PK, Appel LJ, Espeland MA, et al; TONE Collaborative Research Group. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE) [published correction appears in JAMA. 1998;279(24):1954]. JAMA. 1998;279(11):839-846.
15. Trials of Hypertension Prevention Collaborative Research Group. Effects of weight loss and sodium reduction intervention on blood pressure and hypertension incidence in overweight people with high-normal blood pressure: the Trials of Hypertension Prevention, phase II. Arch Intern Med. 1997;157(6):657-667.
16. Shai I, Schwarzfuchs D, Henkin Y, et al; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med. 2008;359(3):229-241.
17. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med. 2009;360(9):859-873.
18. Ley SJ, Metcalf PA, Scragg RK, Swinburn BA. Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Res Clin Pract. 2004;63(2):103-112.
19. Guare JC, Wing RR, Grant A. Comparison of obese NIDDM and nondiabetic women; short- and long-term weight loss. Obes Res. 1995;3(4):329-335.
20. Perri MG, Foreyt JP. Preventing weight regain after weight loss. In: Bray GA, Bouchard C, eds. Handbook of Obesity: Clinical Applications. New York, NY: Marcel Dekker; 2004:185-200.
21. Ditschuneit HH, Flechtner-Mors M, Johnson TD, Adler G. Metabolic and weight-loss effects of a long-term dietary intervention in obese patients. Am J Clin Nutr. 1999;69(2):198-204. (Pubitemid 29065539)
22. Wadden TA, West DS, Neiberg RH, et al; Look AHEAD Research Group. One-year weight losses in the Look AHEAD study: factors associated with success. Obesity (Silver Spring). 2009;17(4):713-722.
23. Wing RR, Epstein LH, Paternostro-Bayles M, Kriska A, Nowalk MP, Gooding W. Exercise in a behavioural weight control programme for obese patients with type 2 (non-insulin-dependent) diabetes. Diabetologia. 1988;31(12):902-909. (Pubitemid 19054761)
24. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29(9):2102-2107.
25. Boulé NG, Kenny GP, Haddad E, Wells GA, Sigal RJ. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in type 2 diabetes mellitus. Diabetologia. 2003;46(8):1071-1081.
26. Vanninen E, Uusitupa M, Siitonen O, Laitinen J, Länsimies E. Habitual physical activity, aerobic capacity and metabolic control in patients with newlydiagnosed type 2 (non-insulin-dependent) diabetes mellitus: effect of 1-year diet and exercise intervention. Diabetologia. 1992;35(4):340-346.
27. Lee CD, Blair SN, Jackson AS. Cardiorespiratory fitness, body composition, and all-cause and cardiovascular disease mortality in men. Am J Clin Nutr. 1999; 69(3):373-380.
28. Church TS, LaMonte MJ, Barlow CE, Blair SN. Cardiorespiratory fitness and body mass index as predictors of cardiovascular disease mortality among men with diabetes. Arch Intern Med. 2005;165(18):2114-2120.
29. Katzmarzyk PT, Church TS, Blair SN. Cardiorespiratory fitness attenuates the effects of the metabolic syndrome on all-cause and cardiovascular disease mortality in men. Arch Intern Med. 2004;164(10):1092-1097.
30. Katzmarzyk PT, Church TS, Janssen I, Ross R, Blair SN. Metabolic syndrome, obesity, and mortality: impact of cardiorespiratory fitness. Diabetes Care. 2005;28(2):391-397. (Pubitemid 40170945)
31. Henry RR, Scheaffer L, Olefsky JM. Glycemic effects of intensive caloric restriction and isocaloric refeeding in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1985;61(5):917-925. (Pubitemid 16218491)
32. Kelley DE, Wing R, Buonocore C, Sturis J, Polonsky K, Fitzsimmons M. Relative effects of calorie restriction and weight loss in noninsulin-dependent diabetes mellitus. J Clin Endocrin Metab. 1993;77(5):1287-1293. (Pubitemid 23345484)
33. Wing RR, Jeffery RW. Effect of modest weight loss on changes in cardiovascular risk factors: are there differences between men and women or between weight loss and maintenance? Int J Obes Relat Metab Disord. 1995;19(1):67-73.
34. Wadden TA, Anderson DA, Foster GD. Two-year changes in lipids and lipoproteins associated with the maintenance of a 5% to 10% reduction in initial weight: some findings and some questions. Obes Res. 1999;7(2):170-171.
35. Sjöström L, Lindroos AK, Peltonen M, et al; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351(26):2683-2693.
36. Sjöström L, Narbro K, Sjöström CD, et al; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357(8):741-752.
37. Looker HC, Knowler WC, Hanson RL. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care. 2001;24(11):1917-1922.
38. Horvath K, Jeitler K, Siering U, et al. Long-term effects of weight-reducing interventions in hypertensive patients: systematic review and meta-analysis. Arch Intern Med. 2008;168(6):571-580.
39. Perreault L, Ma Y, Dagogo-Jack S, et al; Diabetes Prevention Program. Sex differences in diabetes risk and the effect of intensive lifestyle modification in the Diabetes Prevention Program. Diabetes Care. 2008;31(7):1416-1421.
40. Poobalan A, Aucott L, Smith WC, et al. Effects of weight loss in overweight/obese individuals and long-term lipid outcomes: a systematic review. Obes Rev. 2004;5(1):43-50. (Pubitemid 38173593)
41. Wood PD, Stefanick ML, Williams PT, Haskell WL. The effects on plasma lipoproteins of a prudent weight-reducing diet, with or without exercise, in overweight men and women. N Engl J Med. 1991;325(7):461-466.
42. Stefanick ML, Mackey S, Sheehan M, Ellsworth N, Haskell WL, Wood PD. Effects of diet and exercise in men and postmenopausal women with low levels of HDL cholesterol and high levels of LDL cholesterol. N Engl J Med. 1998;339(1):12-20.
43. Frick MH, Elo O, Haapa K, et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia: safety of treatment, changes in risk factors, and incidence of coronary heart disease. N Engl J Med. 1987;317(20):1237-1245. (Pubitemid 17147964)
44. American Diabetes Association. Clinical practice recommendations. Diabetes Care. 2009;32(suppl 1):1-208.
45. Saaddine JB, Cadwell B, Gregg EW, et al. Improvements in diabetes processes of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med. 2006;144(7):465-474.
46. Selvin E, Marinopoulos S, Berkenblit G, et al. Meta-analysis: glycosylated hemoglobin and cardiovascular disease in diabetes mellitus. Ann Intern Med. 2004;141(6):421-431.
47. Vasan RS, Larson MG, Leip EP, et al. Impact of high-normal blood pressure on the risk of cardiovascular disease. N Engl J Med. 2001;345(18):1291-1297.
48. Rubins HB, Robins SJ, Collins D, et al; Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med. 1999;341(6):410-418.
49. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy [published correction appears in N Engl J Med. 2000;342(18):1376]. N Engl J Med. 2000;342(6):381-389.
50. Lindström J, Ilanne-Parikka P, Peltonen M, et al; Finnish Diabetes Prevention Study Group. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368(9548):1673-1679.